Biocatalysts is promoting its Enzyme Development & Manufacturing Service, a capability that the company says is unique.
The service targets manufacturers looking to differentiate their product from the competition who, according to Biocatalysts, are looking to the unique functional capabilities of speciality enzymes to help them achieve this. But, says the company: what if the enzyme those companies identify isn’t available commercially? Where do they go from there?
Academic institutions are one route, Biocatalysts says: however, when it comes to scaling up for a commercial process, those companies will need kilogram rather than gram amounts. According to the company, its Enzyme Development & Manufacturing Service is a unique fast and cost-effective-solution, describing it as a commercially focused service encompassing the cloning, optimisation, scale-up and routine manufacture of intra and extra-cellular enzymes across a wide variety of sectors including food, flavour, fragrance and non-food applications.
Biocatalysts’ ”design for manufacture” approach enables risks to be mitigated by developing an enzyme manufacturing process that is technically and commercially robust, the company claims. Ultimately, Biocatalysts says that it has the ability to transform a concept into a routinely manufactured enzyme in less than 12 months, providing customers with a competitive advantage by providing an opportunity to cost effectively differentiate their product in a short timescale.
